Israeli medical cannabis company, Tikun Olam Cannbit Pharmaceuticals, has signed an unconditional and binding agreement with ITH Pharma UK for the supply of medical cannabis products for distribution in the UK and Northern Ireland.

ITH Pharma Ltd UK will distribute Tikun Olam’s medicinal cannabis oils worth 37 million euros under its three-year contract. The products are sold under ITH, with the company name on the packaging.

In 2020, the Israeli company signed a collaboration agreement with ITH for the supply of CBD oil and other medicinal cannabis products in the UK and has since pushed ahead with last week’s deal.

The deal is part of Tikun Olam’s efforts to expand its overseas market and deliver medical cannabis worldwide. It has also worked with Brazil, Germany, Austria and Switzerland.

Just a day earlier, on Wednesday last week, the company reported that it had officially entered the Brazilian market for the first time after signing an agreement with Brazilian company Ease Labs.

cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});

if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}